The Liquid Biopsies and Cancer Diagnostics lab at the Cancer Research UK Cambridge Institute, University of Cambridge, develops and pioneers new approaches for non-invasive molecular diagnostics for cancer, primarily based on next-generation sequencing (NGS) of circulating cell-free tumour DNA (ctDNA). Led by Dr Rosenfeld and a team of experienced translational genomics scientists, the lab studies large collections of plasma and other samples from cancer patients through an extensive portfolio of clinical studies and collaborations. We develop NGS analysis tools spanning genome-wide and targeted methods for sensitive detection of tumour-derived nucleic acids and aim to progress these into clinical use by proof-of-concept translational studies to demonstrate their utility. We further explore the biophysical properties of ctDNA to study its origins and interactions and to inform the development of increasingly sensitive methods.
The lab and its collaborators have produced some of the key milestones in the liquid biopsy field using gene panels, exome sequencing, and shallow whole genome sequencing to detect, analyse and monitor ctDNA in plasma samples from hundreds of patients with different cancer types. The group is a dynamic mix of molecular biologists, bioinformaticians and clinical fellows providing a unique environment for development and learning in cancer genomics and translational research, with a strong focus on clinical application.
We are seeking to recruit an outstanding lab-based molecular biologist with a PhD, who has extensive experience in the development of next generation sequencing assays, particularly methylation-based assays and/or circulating tumour DNA diagnostic assays in the field of cancer genomics. The successful candidate will play a key role in a large-scale project for earlier diagnosis of cancer, funded by generous grants from Cancer Research UK. The ideal candidate will have considerable experience in lab-based genomic research, particularly in the development of methylation-based assays (essential), experience of enzymatic conversion and/or bisulphite sequencing and strong bioinformatics skills for the analysis of NGS data. Experience of research using human samples, the development of clinical diagnostic assays, and integrating genomic data from multiple sources would be a distinct advantage. You will be a highly motivated, detail-oriented individual with excellent communication skills and who is well organised. You will be able to work independently and interact effectively in a multi-disciplinary team environment.
The closing date for applications is 11th January 2021.
Informal enquiries may be made to the Rosenfeld lab management team by emailing email@example.com
Fixed-term: The funds for this post are available until 29 February 2024 in the first instance.
Once an offer of employment has been accepted, the successful candidate will be required to undergo a security check.
To apply online for this vacancy and to view further information about the role, please visit: http://www.jobs.cam.ac.uk/job/27768.
Please ensure that you upload a covering letter and CV in the Upload section of the online application. The covering letter should outline how you match the criteria for the post and why you are applying for this role. If you upload any additional documents which have not been requested, we will not be able to consider these as part of your application.
Please include details of your referees, including email address and phone number, one of which must be your most recent line manager
Please quote reference SW24828 on your application and in any correspondence about this vacancy.
The University actively supports equality, diversity and inclusion and encourages applications from all sections of society.
The University has a responsibility to ensure that all employees are eligible to live and work in the UK.
|Salary:||£32,816 to £40,322|
|Placed On:||20th November 2020|
|Closes:||11th January 2021|
Type / Role: